GE HealthCare announced it has received 510(k) clearance from the United States Food and Drug Administration FDA for its Portrait Mobile wireless and wearable monitoring solution. The Portrait Mobile platform enables real-time continuous monitoring with a personalized view of the patient’s vitals while keeping patients mobile during critical recovery periods, especially after surgery or discharge from the intensive care unit.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GEHC:
- Adobe upgraded, Salesforce downgraded: Wall Street’s top analyst calls
- BofA starts ‘appropriately valued’ GE HealthCare at Neutral
- GE HealthCare initiated with a Neutral at BofA
- Mizuho healthcare analysts hold an analyst/industry conference call
- GE HealthCare sees FY23 free cash flow conversion of 85% or more